Page last updated: 2024-11-06

phytofluene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

phytofluene: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6857557
CHEBI ID35165
MeSH IDM0044111

Synonyms (20)

Synonym
15-cis-7,8,11,12,7',8'-hexahydro-psi,psi-carotene
(12e,16z,18e,22e,26e)-2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,10,12,14,16,18,22,26,30-decaene
CHEBI:35165
15-cis-phytofluene
phytofluene
27664-65-9
(6e,10e,12e,14e,16z,18e,22e,26e)-2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,10,12,14,16,18,22,26,30-decaene
ibr-clc
omega,omega-carotene, 7,7',8,8',11,12-hexahydro-, 15-cis-
phytofluene, (15z)-
3v8034l59c ,
unii-3v8034l59c
lycopene, 7,7',8,8',11,12-hexahydro-, 15-cis-
cis-phytofluene
.omega.,.omega.-carotene, 7,7',8,8',11,12-hexahydro-, 15-cis-
cis-7,7',8,8',11,12-hexahydro-carotene
(15z)-phytofluene
DTXSID40904730
Q3746185
psi,psi-carotene, 7,7',8,8',11,12-hexahydro-, 15-cis-

Research Excerpts

Bioavailability

Phytofluene displays a higher bioavailability compared to carotenoids such as lutein, β-carotene or lycopene. Phyto Fluene bioavailability is positively correlated with fasting plasma phyto fluene concentration (r = 0.0).

ExcerptReferenceRelevance
"Lycopene from fresh and unprocessed tomatoes is poorly absorbed by humans."( A food-based formulation provides lycopene with the same bioavailability to humans as that from tomato paste.
Applegate, LA; Baur, M; Bortlik, K; Hager, C; Lambelet, P; Liardet, S; Offord, EA; Richelle, M, 2002
)
0.31
" Methods for producing isotopically labeled PE, PF, and LYC tracers from tomato plant cell culture offer a unique tool for further understanding the differential bioavailability and metabolism of these 3 prominent tomato carotenoids and how they may affect health."( Nutritional aspects of phytoene and phytofluene, carotenoid precursors to lycopene.
Clinton, SK; Engelmann, NJ; Erdman, JW, 2011
)
0.37
"The mechanisms as well the genetics underlying the bioavailability and metabolism of carotenoids in humans remain unclear."( Strong and weak plasma response to dietary carotenoids identified by cluster analysis and linked to beta-carotene 15,15'-monooxygenase 1 single nucleotide polymorphisms.
Clevidence, BA; Edwards, AJ; Wang, TT, 2013
)
0.39
" In this work, we review much of the existing knowledge concerning their chemical characteristics, physico-chemical properties, analysis, distribution in foods, bioavailability and likely biological activities."( A comprehensive review on the colorless carotenoids phytoene and phytofluene.
Benítez-González, A; Mapelli-Brahm, P; Meléndez-Martínez, AJ; Stinco, CM, 2015
)
0.42
" Our objective was to compare the bioavailability of lycopene from tangerine to red tomato juice, and elucidate physical deposition forms of these isomers in tomatoes by light and electron microscopy."( Enhanced bioavailability of lycopene when consumed as cis-isomers from tangerine compared to red tomato juice, a randomized, cross-over clinical trial.
Clinton, SK; Cooperstone, JL; Francis, DM; Haufe, TC; King, SA; Lesinski, GB; Ralston, RA; Riedl, KM; Schwartz, SJ; Schweiggert, RM; Timmers, CD, 2015
)
0.42
"The objective was to assess the potential bioavailability of phytoene (PT) and phytofluene (PTF) from tomato powders used as raw materials for supplements as compared to the pulp of a common tomato and a cherry tomato."( Comparative study of the bioaccessibility of the colorless carotenoids phytoene and phytofluene in powders and pulps of tomato: microstructural analysis and effect of addition of sunflower oil.
Mapelli-Brahm, P; Meléndez-Martínez, AJ; Stinco, CM, 2018
)
0.48
" We thus compared carotene bioavailability in mice after gavage with carotene-rich oil-in-water emulsions."( Comparison of the bioavailability and intestinal absorption sites of phytoene, phytofluene, lycopene and β-carotene.
Borel, P; Desmarchelier, C; Halimi, C; Mapelli-Brahm, P; Margier, M; Meléndez-Martínez, AJ; Nowicki, M; Reboul, E, 2019
)
0.51
" The results demonstrated that OT-L could be an excellent raw material to produce tomato products with high bioavailability and bioactivity."( Carotenoid composition and antioxidant activities of Chinese orange-colored tomato cultivars and the effects of thermal processing on the bioactive components.
Jiang, X; Ma, L; Xiong, W; Yang, C; Zhang, J; Zhang, L; Zhang, S, 2021
)
0.62
"Phytofluene is a colorless carotenoid with potential health benefits that displays a higher bioavailability compared to carotenoids such as lutein, β-carotene or lycopene."( The Interindividual Variability of Phytofluene Bioavailability is Associated with a Combination of Single Nucleotide Polymorphisms.
Borel, P; Bott, R; Desmarchelier, C; Lairon, D; Nowicki, M; Zumaraga, MP, 2023
)
0.91
"This study reports a combination of SNPs that is associated with a significant part of the interindividual variability of phytofluene bioavailability in a healthy male adult population."( The Interindividual Variability of Phytofluene Bioavailability is Associated with a Combination of Single Nucleotide Polymorphisms.
Borel, P; Bott, R; Desmarchelier, C; Lairon, D; Nowicki, M; Zumaraga, MP, 2023
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
phytofluene
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (60)

TimeframeStudies, This Drug (%)All Drugs %
pre-199013 (21.67)18.7374
1990's3 (5.00)18.2507
2000's13 (21.67)29.6817
2010's21 (35.00)24.3611
2020's10 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials8 (12.90%)5.53%
Reviews3 (4.84%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other51 (82.26%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]